Search

Displaying results 2241 - 2250 of 10000 in total
  1. Drug

    Odesivimab

    go.drugbank.com/drugs/DB15900
    ApprovedInvestigational

    INMAZEB™ is produced by Regeneron Pharmaceuticals and was granted FDA approval on October 14, 2020.[L17320] … [A221825] Immune therapy using monoclonal antibodies (mAbs) is becoming an increasingly attractive therapeutic method to combat infectious diseases due to its rapid development, low toxicity, and high

    Categories: Amino Acids, Peptides, and Proteins
  2. Target

    Complement C3

    go.drugbank.com/bio_entities/BE0003455
    TargetHumans

    Precursor of non-enzymatic components of the classical, alternative, lectin and GZMK complement pathways, which consist in a cascade of proteins that leads to phagocytosis and breakdown of pathogens and

    Synonyms: C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1
  3. Drug

    Avacincaptad pegol

    go.drugbank.com/drugs/DB15165
    ApprovedInvestigational

    [A260801] Avacincaptag pegol was approved by the FDA on August 4, 2023, under the brand name IZERVAY for the treatment of GA secondary to AMD. … AMD eventually progresses to bilateral and irreversible loss of vision, whether or not the patients have the non-neovascular (dry) or the neovascular (wet) form of AMD.

    Categories: Nucleic Acids, Nucleotides, and Nucleosides
  4. Drug

    Serine

    go.drugbank.com/drugs/DB00133
    ApprovedInvestigationalNutraceutical

    A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from glycine or threonine. It is involved in the biosynthesis of purines; pyrimidines; and other amino acids.

    Mixtures: Aminosyn II and Dextrose, Aminosyn II and DextroseCategories: Amino Acids, Peptides, and Proteins
  5. Drug

    Nelarabine

    go.drugbank.com/drugs/DB01280
    ApprovedInvestigational

    [A258719] Nelarabine was first granted accelerated approval by the FDA on October 28, 2005, and was manufactured under the trademark name ARRANON by GlaxoSmithKline. … [A2332] Due to the rarity of these T-cell malignancies, nelarabine was first granted orphan drug status and a fast-track designation by the FDA to address the unmet therapeutic needs of these cancers.

    Categories: Antineoplastic and Immunomodulating Agents, Nucleic Acids, Nucleotides, and Nucleosides
  6. Drug

    Mupirocin

    go.drugbank.com/drugs/DB00410
    ApprovedInvestigationalVet approved

    _ and traumatic skin lesions due to secondary skin infections caused by _S. aureus_ and _S. pyogenes_. … [L10580] It is available in topical formulations only due to extensive systemic metabolism[A178531] and is used in the treatment of impetigo caused by _Staphylococcus aureus_ and _Streptococcus pyogenes

    Mixtures: Pre and Post Sx Pouch
  7. Indication

    Coronary artery thrombosis

    go.drugbank.com/conditions/DBCOND0007525
    Drugs: Atorvastatin
    Synonyms: Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
  8. Indication

    Diabetic Retinopathy (DR)

    go.drugbank.com/conditions/DBCOND0118126
    Drugs: Aflibercept · Ranibizumab
    Synonyms: Retinopathy co-occurrent and due to diabetes mellitus
  9. Indication

    Hyperemesis Gravidarum

    go.drugbank.com/conditions/DBCOND0001432
    Drugs: Cocarboxylase
    Synonyms: Persistent AND/OR vicious vomiting arising during pregnancy
  10. Indication

    Ophthalmia Neonatorum

    go.drugbank.com/conditions/DBCOND0000276
    Drugs: Erythromycin
    Synonyms: Neonatal conjunctivitis and dacryocystitis